Latest Ischemia Stories
PORTOLA VALLEY, Calif., Nov. 2, 2010 /PRNewswire/ -- Spectros Corporation presented new clinical results using tissue oxygen saturation with the T-Stat VLS Tissue Oximeter at the San Diego Convention Center during Anesthesiology 2010. This newly released data was presented during poster sessions entitled "Experimental Circulation: Ischemia and Reperfusion" and "Clinical Circulation: Pharmacology/Physiology", held at the American Society of Anesthesiologists (ASA 2010) on October 16, 2010 in...
Statement highlights:   * Measures to avoid a second or subsequent stroke include treating metabolic syndrome and undergoing carotid angioplasty.   * Standard antiplatelet drug therapies are equally effective; so a tailored treatment regimen is advised based on individual risk factors and characteristics.Treating metabolic syndrome and undergoing carotid angioplasty may prevent recurrent stroke or transient ischemic attack (TIA), according to revised American Heart...
MOUNTAIN VIEW, Calif., Oct. 8 /PRNewswire/ -- Concentric Medical, Inc. today announced the full European launch of Trevo(TM), the first device utilizing Stentriever(TM) technology for clot retrieval in ischemic stroke patients. Trevo is the newest offering in a portfolio of products from Concentric Medical, the company that first introduced retrievers for acute ischemic stroke. The Trevo's stent-like design leverages the company's long history of developing clot retrieval technologies for...
SAN DIEGO, Oct. 6 /PRNewswire/ -- Sangart, Inc., today announced that it has been awarded a $1.1 million grant from the U.S. Department of Defense to support the development of its novel product platform based on the MP4 molecule, an investigational biopharmaceutical product designed to enhance the perfusion and oxygenation of oxygen-deprived tissues and provide targeted oxygen delivery to the capillaries in severely injured trauma patients. This award funds further pre-clinical development...
MOUNTAIN VIEW, Calif., Oct. 4 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced that the Merci Retriever® has recently received both product and procedure reimbursement from the Japanese Ministry of Health, Labor and Welfare. The Merci Retriever is a catheter-based medical device that physicians at stroke centers use to remove blood clots from the brains of patients suffering an ischemic stroke. On May...
MOUNTAIN VIEW, Calif., Sept. 30 /PRNewswire/ -- Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced the start of the TREVO Study. The first patients were enrolled and successfully treated at the Hospital Clinic de Barcelona by the Neuroradiology team of Drs. Juan Macho and Jordi Blasco. The TREVO Study (Thrombectomy REvascularization of large Vessel Occlusions in acute ischemic stroke) is the first to evaluate Stentriever(TM) technology in a...
(Ivanhoe Newswire) --Â Â Stroke is the third leading cause of death in the U.S., and if a stroke doesn't kill you it causes debilitating problems that significantly affect a person's quality of life. A team of scientists have discovered an enzyme responsible for nerve cell death after a stroke that can decrease brain damage and preserve brain function.The enzyme that was discovered is NOX4, and it produces hydrogen peroxide. When NOX4 was inhibited by a new drug in mice during an...
SAN DIEGO, Aug. 31 /PRNewswire/ -- Sangart, Inc., today announced positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients. During hemorrhagic shock, inadequate perfusion of critical organs can lead to insufficient...
SAN DIEGO, June 29 /PRNewswire/ -- Sangart, Inc., today announced that enrollment was completed in a Phase IIa clinical study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. Complete study results are expected, after follow up of outcomes in these patients, in the second half of 2010. "The hemorrhagic shock that results from severe trauma can cause organ dysfunction and even death," said Karim Brohi, global...
TEL AVIV, Israel, June 29, 2010 /PRNewswire-FirstCall/ -- BSP, which develops and commercializes advanced products for the non invasive, accurate diagnosis of heart diseases, announced today that its Add-On product, the HyperQ AD-100 (http://www.bsp.co.il/pdf/HyperQ AD-100 Pic.pdf), intended for improved diagnostic performance of Stress ECG, has been granted the European CE conformance mark. The HyperQ AD-100 product is an add-on system with the HyperQ technology which is incorporated...
